verapamil hydrochloride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68462-260
  • Package NDC 68462-260-01
  • Package NDC 68462-260-05
  • Package NDC 68462-260-10
  • Package NDC 68462-260-30
  • Package NDC 68462-260-90
  • Application number ANDA078906
  • SPL ID c4ac347e-78cd-490d-9047-73a1df2bd717
  • SPL set ID ba1bf1ae-9347-4d17-998b-14bf7b5984ce
  • UNII V3888OEY5R
  • RxCUI 897640
  • RxCUI 897649
  • RxCUI 897659

What the source publishes

Labeler
Glenmark Pharmaceuticals Inc., USA
Active ingredients
verapamil hydrochloride
Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68462-260_c4ac347e-78cd-490d-9047-73a1df2bd717
{
  "name": "verapamil hydrochloride",
  "splId": "c4ac347e-78cd-490d-9047-73a1df2bd717",
  "labels": [
    {
      "setId": "ba1bf1ae-9347-4d17-998b-14bf7b5984ce",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba1bf1ae-9347-4d17-998b-14bf7b5984ce",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ba1bf1ae-9347-4d17-998b-14bf7b5984ce"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Glenmark Pharmaceuticals Inc., USA",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-01)",
      "package_ndc": "68462-260-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20090917"
    },
    {
      "sample": false,
      "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-05)",
      "package_ndc": "68462-260-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20090917"
    },
    {
      "sample": false,
      "description": "1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-10)",
      "package_ndc": "68462-260-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20090917"
    },
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-30)",
      "package_ndc": "68462-260-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20090917"
    },
    {
      "sample": false,
      "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-260-90)",
      "package_ndc": "68462-260-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20090917"
    }
  ],
  "productId": "68462-260_c4ac347e-78cd-490d-9047-73a1df2bd717",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
  "productNdc": "68462-260",
  "deaSchedule": null,
  "genericName": "verapamil hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "VERAPAMIL HYDROCHLORIDE",
      "strength": "240 mg/1"
    }
  ],
  "applicationNumber": "ANDA078906",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20090917",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0368462292013",
      "0368462293010",
      "0368462260012"
    ],
    "unii": [
      "V3888OEY5R"
    ],
    "rxcui": [
      "897640",
      "897649",
      "897659"
    ],
    "spl_set_id": [
      "ba1bf1ae-9347-4d17-998b-14bf7b5984ce"
    ],
    "manufacturer_name": [
      "Glenmark Pharmaceuticals Inc., USA"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68462-260_c4ac347e-78cd-490d-9047-73a1df2bd717"